Cargando…

Clinical profile of chronic bronchial asthma patients in Poland: results of the PROKSAL study

INTRODUCTION: Asthma is a complex condition characterized by the presence of chronic inflammation in the lower respiratory tract resulting in many disturbing symptoms. The study of the clinical profile of the population with asthma allows us to understand a trend of a specific disease taking into ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Banasiak, Hanna, Pawliczak, Rafał
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874873/
https://www.ncbi.nlm.nih.gov/pubmed/33603604
http://dx.doi.org/10.5114/ada.2020.102102
Descripción
Sumario:INTRODUCTION: Asthma is a complex condition characterized by the presence of chronic inflammation in the lower respiratory tract resulting in many disturbing symptoms. The study of the clinical profile of the population with asthma allows us to understand a trend of a specific disease taking into account several indicators and its clinical characteristics. AIM: Evaluation of the clinical profile of patients with chronic bronchial asthma in Poland. MATERIAL AND METHODS: The study included 10400 adult patients, of both sexes, diagnosed with chronic bronchial asthma who started therapy based on inhaled glucocorticosteroids accompanied by salmeterol, and 52 allergists. The examination was performed in a doctor’s surgery. Standardized questionnaire interviews were used in order to carry out the procedure. RESULTS: The age of the patients ranged from 18 up to 97 years. Most of them suffer from overweight and obesity. 45.3% of the patients smoked cigarettes or declared to be passive smokers. Current asthma control was poor: over 56% of the patients suffered from diurnal symptoms more often than twice a week, almost 55% from nocturnal symptoms, in 72% of the patients’ physical activity was limited, whereas 57% required immediate treatment. Most commonly used drugs were inhaled glucocorticosteroids and short acting β2-mimetics. After treatment change, fewer patients suffered from asthma symptoms. CONCLUSIONS: Adjusting the therapy according to the current guidelines and to the patient’s needs helps to improve asthma control.